An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
Clinical trial NCT05399368 · TERMINATED
Trial details
- NCT number
- NCT05399368
- Sponsor
- RAPT Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2024-05-24
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.